Monkeypox Information and Resources
In light of the recent cases of monkeypox in the U.S., the National Coalition for LGBTQ Health has curated a library of evidence-based materials in multiple formats about monkeypox. Geared to clinicians, researchers, and community members, the resources provide information about monkeypox virus transmission, prevention, testing, and treatment.
Letter from CDC Director Dr. Rochelle Walensky
Resources from CDC
Scientists at the Centers for Disease Control and Prevention (CDC) are tracking multiple cases of monkeypox that have been reported in several countries that don’t normally report monkeypox, including the United States.
It’s not clear how the people were exposed to monkeypox, but early data suggest that gay, bisexual, and other men who have sex with men make up a high number of cases. However, anyone who has been in close contact with someone who has monkeypox is at risk. CDC is urging healthcare providers in the U.S. to be alert for patients who have rash illnesses consistent with monkeypox, regardless of whether they have travel or specific risk factors for monkeypox and regardless of gender or sexual orientation.
CDC is working with state and local health officials to identify people who may have been in contact with individuals who have tested positive for monkeypox, so they can monitor their health.
General
Community
- Travelers’ Health Alert
- Monkeypox: Get the Facts
- Reducing Stigma in Monkeypox Communication and Community Engagement
- Guidance for social gatherings and safer sex
- New video featuring CDC’s Dr. Demetre Daskalakis on HIV.gov with Kaye Hayes, MPA, Deputy Assistant Secretary for Infectious Disease and the Director of the Office of Infectious Disease and HIV/AIDS Policy
Morbidity and Mortality Weekly Report (MMWR)
Additional Resources
For Clinicians
- Information For Healthcare Professionals
- Clinician FAQs
- Case Definition†
- Clinical Recognition
- Infection Control: Healthcare Settings
- Infection Control: Home
- Specimen Collection
- Treatment
- Vaccine Guidance
- Duration of Isolation Procedures
- Monitoring Persons Exposed
- Autopsy and Handling of Human Remains
- Webinar May 24, 2022 – What Clinicians Need to Know about Monkeypox in the United States and Other Countries (cdc.gov)
- Slides [PDF]
- Transcript [PDF]
- HAN Archive – 00466 | Health Alert Network (HAN) (cdc.gov)
- Tecovirimat Clinician guidance
- Updated MPX rash photos on Signs & Symptoms and Clinical Recognition
- Preparation and collection of specimens
- Information for Healthcare Providers on Obtaining and Using TPOXX (Tecovirimat) for Treatment of Monkeypox
CDC, in partnership with FDA, has made it easier for healthcare providers to provide tecovirimat (TPOXX) treatment to patients with monkeypox under the expanded access investigational new drug (EA-IND). The streamlined process allows healthcare providers to start treatment before the paperwork is submitted, and reduces the number of required forms, patient samples, photos, and gives patients the option to see their doctor virtually.
